Stockscreener 앱 받기
92.28
2.10%
-1.98
시간 외 거래:
92.27
-0.01
-0.01%
전일 마감가:
$94.26
열려 있는:
$94
하루 거래량:
149.60K
Relative Volume:
0.94
시가총액:
$2.09B
수익:
$213.03M
순이익/손실:
$41.32M
주가수익비율:
50.43
EPS:
1.83
순현금흐름:
$33.49M
1주 성능:
+13.87%
1개월 성능:
+9.97%
6개월 성능:
-5.83%
1년 성능:
+11.27%
1일 변동 폭
$90.93
$94.61
1주일 범위
$81.49
$97.02
52주 변동 폭
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
명칭
Lemaitre Vascular Inc
전화
781-221-2266
주소
63 SECOND AVENUE, BURLINGTON, MA
LMAT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
92.28 | 2.11B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
470.08 | 169.94B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
193.50 | 49.41B | 21.39B | 1.59B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
283.90 | 41.12B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
85.75 | 41.61B | 9.93B | 1.12B | 1.58B | 2.25 |
|
WST
West Pharmaceutical Services Inc
|
240.98 | 17.06B | 2.90B | 467.20M | 306.90M | 6.37 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-02-13 | 개시 | Wells Fargo | Equal Weight |
| 2024-10-15 | 개시 | Cantor Fitzgerald | Neutral |
| 2024-08-02 | 재개 | Lake Street | Buy |
| 2024-05-31 | 재개 | ROTH MKM | Buy |
| 2024-04-26 | 업그레이드 | Stifel | Hold → Buy |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-06 | 개시 | Oppenheimer | Outperform |
| 2023-08-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-05-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | 개시 | Jefferies | Buy |
| 2021-02-12 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | 업그레이드 | Sidoti | Neutral → Buy |
| 2019-10-24 | 다운그레이드 | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | 업그레이드 | Lake Street | Hold → Buy |
| 2019-10-14 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | 재확인 | Barrington Research | Outperform |
| 2019-07-25 | 업그레이드 | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2018-06-08 | 재개 | ROTH Capital | Buy |
| 2018-04-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-04-26 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2017-10-27 | 다운그레이드 | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2017-07-10 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2017-03-21 | 개시 | First Analysis Sec | Overweight |
| 2017-02-22 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2016-07-28 | 재확인 | Barrington Research | Outperform |
| 2016-02-25 | 재확인 | Barrington Research | Outperform |
모두보기
Lemaitre Vascular Inc 주식(LMAT)의 최신 뉴스
Insider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) CEO Sells 100,000 Shares of Stock - MarketBeat
Cantor Fitzgerald Issues Positive Forecast for LeMaitre Vascular (NASDAQ:LMAT) Stock Price - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Announces Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Issues Q3 2025 Earnings Guidance - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Plans $0.20 Quarterly Dividend - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Issues FY 2025 Earnings Guidance - MarketBeat
LeMaitre Vascular Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Research Analysts Issue Forecasts for LMAT Q3 Earnings - MarketBeat
Barrington Research Has Positive Outlook of LMAT Q3 Earnings - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Rating Increased to Outperform at Barrington Research - MarketBeat
Lemaitre Vascular Insider Sales: Signal of Caution or Strategic Wealth Management? - AInvest
Q2 EPS Estimate for LeMaitre Vascular Lifted by Analyst - MarketBeat
LeMaitre Vascular To Go Ex-Dividend On August 21st, 2025 With 0.2 USD Dividend Per Share - 富途牛牛
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q2 2025 Earnings Call Transcript - Insider Monkey
LeMaitre Vascular’s Earnings Call Highlights Growth - TipRanks
LeMaitre Vascular Beats Expectations With Strong Sales And Profits - Finimize
Why LeMaitre (LMAT) Stock Is Trading Up Today - TradingView
LeMaitre Vascular Breaks Above 200-Day Moving AverageBullish for LMAT - Nasdaq
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Could Be 25% Above Their Intrinsic Value Estimate - simplywall.st
LEMAITRE VASCULAR INC SEC 10-Q Report - TradingView
LeMaitre (LMAT) Q2 Revenue Jumps 15% - sharewise.com
LeMaitre Vascular Reports Impressive Q2 2025 Financial ResultsNews and Statistics - IndexBox
LeMaitre Vascular Q2 Earnings, Revenue Rise; Raises 2025 Guidance - MarketScreener
LeMaitre raises 2025 revenue guidance to $251M with 15% organic growth as international launches accelerate - MSN
LeMaitre: Q2 Earnings Snapshot - New Haven Register
LeMaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo Finance
LeMaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Highlights: S - GuruFocus
LeMaitre (LMAT) Q2 Revenue Jumps 15% - The Motley Fool
LeMaitre Vascular's Q2 2025 Earnings Call: Unpacking Key Contradictions in Sales Growth, Pricing Strategies, and Market Opportunities - AInvest
LeMaitre Vascular Reports Strong Q2 2025 Growth - TipRanks
LeMaitre Vascular Ups Guidance After Strong Q2 Sales Jump - Finimize
Earnings call transcript: LeMaitre Vascular Q2 2025 earnings beat forecasts By Investing.com - Investing.com Canada
LeMaitre Vascular (LMAT) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
LeMaitre (NASDAQ:LMAT) Exceeds Q2 Expectations, Full-Year Sales Guidance is Optimistic - TradingView
LeMaitre Vascular earnings beat by $0.03, revenue topped estimates - Investing.com South Africa
Medical device firm LeMaitre Q2 sales beat expectations - MarketScreener
LeMaitre Vascular, Inc. Reports Q2 2025 Financial Results, Announces Dividend, and Raises Guidance - Quiver Quantitative
LeMaitre Q2 2025 Financial Results - GlobeNewswire
Why LeMaitre Vascular Inc. stock attracts strong analyst attentionLow Risk Trade Timing with Analysis Metrics - Newser
Detecting support and resistance levels for LeMaitre Vascular Inc.Consistent Profit Signals with AI Models - Newser
Ranking LeMaitre Vascular Inc. among high performing stocks via toolsWeekly Stock Market Strategy Summary - Newser
Using Python tools to backtest LeMaitre Vascular Inc. strategiesBuy Entry Confirmation Based on Technical Analysis - Newser
MACD Cross Could Confirm Trend in LeMaitre Vascular Inc.Growth Based Stock Signal Screener Updated - metal.it
How to interpret RSI for LeMaitre Vascular Inc. stockTechnical Analysis of Growth Stock Opportunities - Newser
LeMaitre Vascular's Financial Results: What to ExpectNews and Statistics - IndexBox
Lemaitre Vascular Inc (LMAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.80%
자본화:
|
볼륨(24시간):